Bristol Myers Squibb Stock Buy Hold or Sell Recommendation
| BMYMP Stock | USD 1,006 15.55 1.57% |
Assuming the 90 days horizon and your complete indifference towards market risk, our recommendation regarding Bristol Myers Squibb is 'Strong Hold'. A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Bristol Myers Squibb given historical horizon and risk tolerance towards Bristol-Myers Squibb. When Macroaxis issues a 'buy' or 'sell' recommendation for Bristol Myers Squibb, the advice is generated through an automated system that utilizes algorithms and statistical models.
Check out Bristol-Myers Squibb Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. To learn how to invest in Bristol-Myers Pink Sheet, please use our How to Invest in Bristol-Myers Squibb guide. Note, we conduct extensive research on individual companies such as Bristol-Myers and provide practical buy, sell, or hold advice based on investors' constraints. Bristol Myers Squibb. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.
Bristol-Myers |
Execute Bristol-Myers Squibb Buy or Sell Advice
The Bristol-Myers recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Bristol Myers Squibb. Macroaxis does not own or have any residual interests in Bristol Myers Squibb or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Bristol-Myers Squibb's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Hold
Market Performance | OK | Details | |
Volatility | Very steady | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Moves indifferently to market moves | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Inapplicable | Details |
Bristol-Myers Squibb Trading Alerts and Improvement Suggestions
| Bristol Myers Squibb had very high historical volatility over the last 90 days |
Bristol-Myers Squibb Returns Distribution Density
The distribution of Bristol-Myers Squibb's historical returns is an attempt to chart the uncertainty of Bristol-Myers Squibb's future price movements. The chart of the probability distribution of Bristol-Myers Squibb daily returns describes the distribution of returns around its average expected value. We use Bristol Myers Squibb price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Bristol-Myers Squibb returns is essential to provide solid investment advice for Bristol-Myers Squibb.
| Mean Return | 0.46 | Value At Risk | -0.07 | Potential Upside | 3.84 | Standard Deviation | 3.39 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Bristol-Myers Squibb historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Bristol-Myers Squibb Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Bristol-Myers Squibb or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Bristol-Myers Squibb's price will be affected by overall pink sheet market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Bristol-Myers pink sheet's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 0.45 | |
β | Beta against Dow Jones | -0.04 | |
σ | Overall volatility | 3.47 | |
Ir | Information ratio | 0.1 |
Bristol-Myers Squibb Volatility Alert
Bristol Myers Squibb exhibits very low volatility with skewness of 2.23 and kurtosis of 12.37. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Bristol-Myers Squibb's pink sheet risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Bristol-Myers Squibb's pink sheet price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Bristol-Myers Squibb Fundamentals Vs Peers
Comparing Bristol-Myers Squibb's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Bristol-Myers Squibb's direct or indirect competition across all of the common fundamentals between Bristol-Myers Squibb and the related equities. This way, we can detect undervalued stocks with similar characteristics as Bristol-Myers Squibb or determine the pink sheets which would be an excellent addition to an existing portfolio. Peer analysis of Bristol-Myers Squibb's fundamental indicators could also be used in its relative valuation, which is a method of valuing Bristol-Myers Squibb by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Bristol-Myers Squibb to competition |
| Fundamentals | Bristol-Myers Squibb | Peer Average |
| Revenue | 46.38 B | 9.43 B |
| EBITDA | 20.1 B | 3.9 B |
| Net Income | 7.01 B | 570.98 M |
| Cash And Equivalents | 6.07 B | 2.7 B |
| Cash Per Share | 3.72 X | 5.01 X |
| Total Debt | 39.6 B | 5.32 B |
| Debt To Equity | 59.40 % | 48.70 % |
| Current Ratio | 1.40 X | 2.16 X |
| Book Value Per Share | 7.55 X | 1.93 K |
| Cash Flow From Operations | 16.21 B | 971.22 M |
| Number Of Employees | 23.7 K | 18.84 K |
| Beta | 0.35 | -0.15 |
| Market Capitalization | 2.11 T | 19.03 B |
| Total Asset | 109.31 B | 29.47 B |
| Annual Yield | 0 % | |
| Net Asset | 109.31 B | |
| Last Dividend Paid | 1.59 |
Bristol-Myers Squibb Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Bristol-Myers . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Daily Balance Of Power | 9.2 T | |||
| Rate Of Daily Change | 1.02 | |||
| Day Median Price | 1005.55 | |||
| Day Typical Price | 1005.55 | |||
| Price Action Indicator | 7.77 | |||
| Period Momentum Indicator | 15.55 | |||
| Relative Strength Index | 42.29 |
About Bristol-Myers Squibb Buy or Sell Advice
When is the right time to buy or sell Bristol Myers Squibb? Buying financial instruments such as Bristol-Myers Pink Sheet isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Bristol-Myers Squibb in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Precious Metals ETFs Thematic Idea Now
Precious Metals ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Precious Metals ETFs theme has 28 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Precious Metals ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Bristol-Myers Pink Sheet Analysis
When running Bristol-Myers Squibb's price analysis, check to measure Bristol-Myers Squibb's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bristol-Myers Squibb is operating at the current time. Most of Bristol-Myers Squibb's value examination focuses on studying past and present price action to predict the probability of Bristol-Myers Squibb's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bristol-Myers Squibb's price. Additionally, you may evaluate how the addition of Bristol-Myers Squibb to your portfolios can decrease your overall portfolio volatility.